Table III.
Univariate analysis of the prognostic factors for survival in the ASCT group.
| Factors | n | PFS (months)a | P-value | 3-year OS (%) | P-value |
|---|---|---|---|---|---|
| DS stage | 0.903 | 0.407 | |||
| II | 14 | 42±7.574 | 81.3 | ||
| III | 28 | 39±7.907 | 88.5 | ||
| ISS stage | 0.781 | 0.625 | |||
| I+II | 33 | 42±6.674 | 86.7 | ||
| III | 9 | 38±10.474 | 83.3 | ||
| Response after ASCT | 0.020 | 0.067 | |||
| CR | 29 | 45±2.553 | 94.7 | ||
| VGPR | 10 | 30±4.714 | 62.5 | ||
| PR | 3 | 17±5.715 | 66.7 | ||
| Maintenance therapy | 0.408 | 0.038 | |||
| Yes | 25 | 42±4.812 | 92.9 | ||
| No | 17 | 34±5.837 | 77.0 |
a
Presented as mean ± standard deviation. ASCT, autologous hematopoietic stem cell transplantation; DS, Durie-Salmon staging system; ISS, international staging system; CR, complete response; PR, partial response; VGPR, very good PR; PFS, progression-free survival; OS, overall survival.